Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
2006-03-06
2009-12-08
Saoud, Christine J (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C530S350000, C530S402000, C424S085100, C424S085200, C435S069100, C536S023500
Reexamination Certificate
active
07629441
ABSTRACT:
The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.
REFERENCES:
patent: 5194381 (1993-03-01), Yanai et al.
patent: 5480956 (1996-01-01), Yanai et al.
patent: 5508291 (1996-04-01), Yanai et al.
patent: 5714382 (1998-02-01), Yanai et al.
patent: 5831023 (1998-11-01), Capon et al.
patent: 0 186 098 (1986-07-01), None
patent: 0 322 870 (1989-07-01), None
patent: 0 414 355 (1991-02-01), None
patent: 0 759 468 (1997-02-01), None
patent: 0 875 251 (1998-11-01), None
patent: WO 94/04680 (1994-03-01), None
patent: WO 99/61618 (1999-12-01), None
Wonderling et al. (2002) et al. Cloning, expression, purification, and biological activity of five feline type I interferons , Veterinary Immunology and Immunopathology, vol. 89, pp. 13-27.
Armitage et al.,Seminars in Immunology, vol. 5, 1993, pp. 401-412.
Armitage et al.,Nature, vol. 357, 1992, pp. 80-82.
Azuma et al.,Nucleic Acids Research, vol. 14, No. 22, 1986, pp. 9149-9158.
Brown et al.,Journal of Immunology, vol. 142, No. 2, 1989, pp. 679-687.
Cantrell et al.,Proc. Natl., Acad. Sci. USA, vol. 82, 1985, pp. 6250-6254.
Daugherty et al.,Journal of Interferon Research, vol. 4, 1984, pp. 635-643.
Dion et al.,Biochemical and Biophysical Research Communications, vol. 138, No. 2, 1986, pp. 826-834.
Drexler,Leukemia, vol. 10, 1996, pp. 588-599.
Feng et al.,J. Mol. Evol., vol. 21, 1985, pp. 112-125.
Gauchat et al.,Res. Immunol., vol. 145(3), Mar.-Apr. 1994, pp. 240-249.
Gauchat et al.,FEBS 11964, vol. 315, No. 3, 1993, pp. 259-266.
Goeddel et al.,Nature, vol. 290, 1981, pp. 20-26.
Gough et al.,The EMBO Journal, vol. 4, No. 3, 1985, pp. 645-653.
Graf et al.,Eur. J. Immunol., vol. 22, 1992, pp. 3191-3194.
Grimaldi et al.,Journal of Immunology, vol. 149, No. 12, 1992, pp. 3921-3926.
Hannum et al.,Nature, vol. 368, 1994, pp. 643-648.
Heussler et al.,Gene, vol. 114, 1992, pp. 273-278.
Himmler et al.,Journal of Interferon Research, vol. 7, 1987, pp. 173-183.
Hirano et al.,Immunology, vol. 90, 1997, pp. 294-300.
Hollenbaugh et al.,The EMBO Journal, vol. 11, No. 12, 1992, pp. 4313-4321.
Inumaru et al.,Immunology and Cell Biology, vol. 73, 1995, pp. 474-476.
Johnson et al.,J. Mol. Biol., vol. 233, 1993, pp. 716-738.
Kelley et al.,Nucleic Acids Research, vol. 13, No. 3, 1985, pp. 805-823.
Lakkis et al.,Biochemical and Biophysical Research Communications, vol. 197, No. 2, 1993, pp. 612-618.
Leong et al.,Veterinary Immunology and Immunopathology, vol. 21, 1989, pp. 261-278.
Lerner et al., GenBank Accession No. U39634, submitted Oct. 27, 1995.
Lerner et al., GenBank Accession No. AAB42052 (U39634.1), submitted Oct. 27, 1995.
Lyman et al.,Blood, vol. 83, No. 10, 1994, pp. 2795-2801.
Lyman et al.,Oncogene, vol. 10, 1995, pp. 149-157.
Lyman et al.,Cell, vol. 75, 1993, pp. 1157-1167.
Lyman et al.,Oncogene, vol. 11, 1995, pp. 1165-1172.
McClanahan et al.,Blood, vol. 88, No. 9, 1996, pp. 3371-3382.
McInnes et al.,Gene, vol. 105, 1991, pp. 275-279.
McKenzie et al.,Proc. Natl. Acad. Sci. USA, vol. 90, 1993, pp. 3735-3739.
Mertens et al.,Immunogenetics, vol. 42, 1995, pp. 430-431.
Minty et al.,Nature, vol. 362, 1993, pp. 248-250.
Nagata et al.Nature, vol. 287, 1980, pp. 401-408.
Nakamura et al.,Biosci. Biotech. Biochem., vol. 56, No. 2, 1992, pp. 211-214.
Nash et al.,Blood, vol. 78, No. 4, 1991, pp. 930-937.
Navarro et al.,J. Gen. Virol. vol. 70, 1989, pp. 1381-1389.
O'Brien et al.,Immunology and Cell Biology, vol. 69, 1991, pp. 51-55.
Osorio et al.,Vaccine, vol. 17, 1999, pp. 1109-1116.
Padrid et al.,AJVR, vol. 59, No. 10, 1998, pp. 1263-1269.
Patterson et al.,Journal of Clinical Investigation, vol. 44, No. 1, 1965, pp. 140-148.
Seow et al.,Gene, vol. 124, 1993, pp. 291-293.
Sideras et al.,Adv. Exp. Med. Biol., vol. 213, 1987, pp. 227-236.
Stamenkovic et al.,The EMBO Journal, vol. 8, No. 5, 1989, pp. 1403-1410.
Torres et al.,Journal of Immunology, vol. 148, No. 2, 1992, pp. 620-626.
Wong et al.,Science, vol. 228, 1985, pp. 810-815.
Yokota et al.,Proc. Natl. Acad. Sci. USA, vol. 83, 1986, pp. 5894-5898.
Zhou et al., GenBank Accession No. L12991, (1993).
Van Der Kaaij, et al., 1999, “Immunogenetics,” vol. 49, pp. 142-143.
Ueda, et al., 1993,Journal of Veterinary Medical Science, vol. 55, No. 2, pp. 251-258, XP001001462.
Lakkis, et al., 1997,Biochemical and Biophysical Research Communications, vol. 235, pp. 529-532.
de Vries, Jan E., 1998,J Allergy Clin lmmunol, vol. 102, pp. 165-169.
Muchamuel, et al., 1997,The Journal of Immunology, vol. 158, pp. 2898-2903.
Brombacher, 2000,BioEssays, vol. 22, pp. 646-656.
Yang, et al., 2000,J Interferon Cytokine Res., vol. 20(9), pp. 779-785.
Rosenberg, et al., 2000,Science, vol. 287, p. 1751.
Juengst, 2003,BMJ, vol. 326, pp. 1410-1411.
Verma, et al., 1997,Nature, vol. 389, pp. 239-242.
Touchette, 1996,Nat. Med., vol. 2(1), pp. 7-8.
Ngo, in the Protein Folding Problem and Tertiary Structure Prediction, Merz et al. (eds.), Birkhauser Boston: Boston, MA, pp. 433 and 492-495, 1994.
Rudinger, in Peptide Hormones, Parsons (ed.), University Park Press: Baltimore, MD, pp. 1-7, 1976.
Heska Corporation
Saoud Christine J
Seharaseyon Jegatheesan
Sheridan & Ross P.C.
LandOfFree
Feline interferon-alpha proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Feline interferon-alpha proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Feline interferon-alpha proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4083568